Why insider trading matters?
What separates FormWhispers.com from others is that we created it to meet our own needs and we use it everyday to make better investment decisions. We will keep improving it to serve us better and to serve you better.
Why insider trading matters?
What separates FormWhispers.com from others is that we created it to meet our own needs and we use it everyday to make better investment decisions. We will keep improving it to serve us better and to serve you better.
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, provides novel therapeutics to treat retinal diseases. Its preclinical stage product candidate include KSI-501, a bispecific anti-interleukin 6/VEGF bioconjugate to target inflammation and abnormal angiogenesis in the pathogenesis of retinal vascular diseases. The company's early research pipeline include KSI-601, a triplet inhibitor for dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015.
Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
---|---|---|---|---|---|---|---|
2020-12-23 | EHRLICH JASON | nan | Sell | 6,950 | $144.55 | $1,004,610 | Yes |
2020-11-20 | EHRLICH JASON | nan | Sell | 6,950 | $138.79 | $964,601 | Yes |
2020-11-20 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 1,527,777 | $108.00 | $164,999,916 | No |
2020-10-27 | EHRLICH JASON | nan | Sell | 7,500 | $100.00 | $750,000 | Yes |
2020-10-23 | EHRLICH JASON | nan | Sell | 7,500 | $86.25 | $646,875 | Yes |
2020-10-20 | EHRLICH JASON | nan | Sell | 6,950 | $78.39 | $544,817 | Yes |
2020-10-13 | EHRLICH JASON | nan | Sell | 5,000 | $75.00 | $375,000 | Yes |
2020-10-09 | EHRLICH JASON | nan | Sell | 2,200 | $71.28 | $156,819 | Yes |
2020-09-25 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 48,125 | $56.65 | $2,726,182 | No |
2020-09-24 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 203,047 | $51.71 | $10,498,591 | No |
2020-09-21 | EHRLICH JASON | nan | Sell | 6,950 | $52.40 | $364,182 | Yes |
2020-09-08 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 322,979 | $47.43 | $15,318,311 | No |
2020-08-20 | EHRLICH JASON | nan | Sell | 6,950 | $47.11 | $327,444 | Yes |
2020-08-21 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 203,486 | $48.23 | $9,815,002 | No |
2020-07-20 | EHRLICH JASON | nan | Sell | 6,950 | $50.44 | $350,526 | Yes |
2020-06-22 | EHRLICH JASON | nan | Sell | 6,950 | $60.54 | $420,747 | Yes |
2020-05-20 | EHRLICH JASON | See Remarks | Sell | 6,950 | $60.72 | $421,989 | Yes |
2020-04-20 | EHRLICH JASON | See Remarks | Sell | 6,950 | $54.12 | $376,115 | Yes |
2020-04-09 | EHRLICH JASON | See Remarks | Sell | 2,200 | $48.56 | $106,830 | Yes |
2020-04-02 | Liang Hong | SVP, Discovery Medicine | Sell | 4,000 | $42.34 | $169,360 | No |
2020-03-26 | Liang Hong | SVP, Discovery Medicine | Sell | 4,000 | $47.78 | $191,112 | No |
2020-03-20 | Levy Richard S | Director | Buy | 1,000 | $44.33 | $44,330 | No |
2020-03-20 | EHRLICH JASON | See Remarks | Sell | 6,950 | $45.00 | $312,762 | Yes |
2020-03-19 | Liang Hong | SVP, Discovery Medicine | Sell | 4,000 | $39.45 | $157,811 | No |
2020-03-18 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 150,000 | $39.29 | $5,893,804 | No |
2020-02-26 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 377,249 | $57.87 | $21,830,242 | No |
2019-12-06 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 1,902,173 | $46.00 | $87,499,958 | No |
2018-10-09 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 2,500,000 | $10.00 | $25,000,000 | Yes |
2018-10-09 | PROFUSEK ROBERT | Director | Buy | 10,000 | $10.00 | $100,000 | No |
Insider Smart
Insider Smart